Impact of axillary dissection on staging and regional control in breast tumors ≤ 10 mm: The DBCG experience

Acta Oncologica

Volumn 39, Issue 3, 2000, Pages 283-289

  Axelsson, C K ^a   Rank, F ^a   Blichert Toft, M ^a   Mouridsen, H T ^a   Jensen, M B ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE; AGED; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER CONTROL; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 0033899840     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418600750013023     Document Type: Conference Paper

References (33)

1. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG)
2. The axilla: Not a no-go zone
3. The importance of surgery and accurate axillary staging for survival in breast cancer
4. Routine or delayed axillary dissection for primary breast cancer?
5. Axillary lymph node dissection: Is it required in T1a breast cancer?
6. Predictors of axillary lymph node metastases in patients with T1 breast cancer. A multivariate analysis
7. Predictors of axillary lymph node metastases in patients wilh T1 breast carcinoma
8. Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer
9. Axillary dissection can be avoided in selected breast cancer patients: Analysis of 401 cases
10. Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?
11. Treatment of the axilla in patients with screen-detected breast cancer
12. A description of the register of the nation-wide programme for primary breast cancer
13. Histological grading and prognosis in breast cancer
14. Axillary lymph nodes and breast cancer: A review
15. Axillary lymph node metastasis in carcinoma of the breast
16. Axillary lymph node metastases associated with small invasive breast carcinomas
17. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma
18. Natural history of small breast cancers
19. Is axillary lymph node dissection necessary in routine management of breast cancer? Not Important
20. Axillary lymph node dissection: Is it required in T1a breast cancer?
21. Infiltrating breast carcinoma smaller than 0.5 centimeters. Is lymph node dissection necessary?
22. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: Influence of axillary dissection for treatment of T1a and T1b lesions
23. A comparison of axillary node status between cancers detected at the prevalence and first incidence breast screening rounds
24. Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer
25. Axillary nodal status in women with screen-detected breast cancer
26. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation
27. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who received adjuvant chemotherapy
28. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial
29. Prognostic factors in NSABP studies of women with node-negative breast cancer. National Surgical Adjuvant Breast and Bowel Project
30. Can internal mammary chain treatment decrease the risk of death for patients with medial breast cancers and positive axillary lymph nodes?
31. Prediction of axillary lymph node involvement of women with invasive breast carcinoma: A multivariate analysis
32. The sentinel node and breast cancer